Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Lyra Therapeutics

    Client Virtual Booth

    LYRA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Lyra Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    480 Arsenal Way Watertown, MA 02472
    Telephone
    Telephone
    617.393.4600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lyratherapeutics.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
    Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com/news-release/2024/03/21/2850605/0/en/Lyra-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    21 Mar 2024
    Share Share
    Lyra Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Lyra Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/03/01/2839056/0/en/Lyra-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Mar 2024
    Share Share
    Lyra Therapeutics to Participate in Upcoming Investor Conferences
    Lyra Therapeutics to Participate in Upcoming Investor Conferences

    https://www.globenewswire.com//news-release/2023/11/07/2774905/0/en/Lyra-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    07 Nov 2023
    Share Share
    Lyra Therapeutics Reports Third Quarter 2023 Financial Results
    Lyra Therapeutics Reports Third Quarter 2023 Financial Results

    https://www.globenewswire.com//news-release/2023/11/07/2775550/0/en/Lyra-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    07 Nov 2023
    Share Share
    Lyra Therapeutics Announces Appointment of Ronan O™Brien as Chief Legal Officer
    Lyra Therapeutics Announces Appointment of Ronan O™Brien as Chief Legal Officer

    https://www.globenewswire.com//news-release/2023/10/16/2760477/0/en/Lyra-Therapeutics-Announces-Appointment-of-Ronan-O-Brien-as-Chief-Legal-Officer.html

    GLOBENEWSWIRE
    16 Oct 2023
    Share Share
    Lyra Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220
    Lyra Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220

    https://www.globenewswire.com//news-release/2023/09/12/2741489/0/en/Lyra-Therapeutics-Announces-Positive-Topline-Results-from-BEACON-Phase-2-Study-of-LYR-220-for-the-Treatment-of-Chronic-Rhinosinusitis-CRS-in-Patients-with-Prior-Ethmoid-Sinus-Surge.html

    GLOBENEWSWIRE
    12 Sep 2023
    Share Share
    Lyra touts positive topline PhII data for chronic rhinosinusitis drug
    Lyra touts positive topline PhII data for chronic rhinosinusitis drug

    https://endpts.com/lyra-therapeutics-reports-topline-data-for-chronic-rhinosinusitis-drug/

    Katherine Lewin ENDPTS
    12 Sep 2023
    Share Share
    Lyra Therapeutics to Participate in Upcoming Investor Conferences
    Lyra Therapeutics to Participate in Upcoming Investor Conferences

    https://www.globenewswire.com//news-release/2023/09/06/2738295/0/en/Lyra-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    06 Sep 2023
    Share Share
    Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210
    Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210

    https://www.globenewswire.com//news-release/2023/08/29/2733237/0/en/Lyra-Therapeutics-Fully-Enrolls-Pivotal-Phase-3-ENLIGHTEN-I-Trial-of-LYR-210-for-the-Treatment-of-Chronic-Rhinosinusitis.html

    GLOBENEWSWIRE
    29 Aug 2023
    Share Share
    Lyra Therapeutics Reports Second Quarter 2023 Financial Results
    Lyra Therapeutics Reports Second Quarter 2023 Financial Results

    https://www.globenewswire.com/news-release/2023/08/08/2721084/0/en/Lyra-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    08 Aug 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search